
|Articles|January 1, 2008
Nonmuscle-invasive bladder cancer: Treating initial, recurrent disease
This article guides the clinician in the management of initial and recurrent nonmuscle-invasive bladder cancer.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Published data show rPFS benefit with lutetium Lu 177 vipivotide tetraxetan in mHSPC
2
Neil Baum, MD, and Abraham Morgentaler, MD, discuss the history of testosterone and prostate cancer
3
Elizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab
4
The UroOnc Minute: Navigating BCG Maintenance Therapy in NMIBC, With Mark D. Tyson, II, MD, MPH
5








